MedTrace Logo

Analgesic Efficacy of Intravenous Dexmedetomidine for Supraclavicular Plexus Block

NCT05389852 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-02-08

No results posted yet for this study

Summary

The goal of the study is to compare the duration of analgesia in patients undergoing forearm or hand surgery with a supraclavicular brachial plexus block, who receive either iv dexmedetomidine or placebo.

Conditions

  • Surgery

Interventions

DRUG

Dexmedetomidine

After completion of supraclavicular brachial plexus block patients will receive intravenous dexmedetomidine 1 mcg/kg

Sponsors & Collaborators

  • Hôpital du Valais

    lead OTHER

Principal Investigators

  • Sina Grape, MD, MBA · Valais Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-01-01
Primary Completion
2024-02-07
Completion
2024-02-07

Countries

  • Switzerland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05389852 on ClinicalTrials.gov